SIMILAR PATTERNS OF AMINO ACIDS FOR 6INE_A_SAMA2304_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 160TRP A 161ASN A 241HIS A 242TYR A 283CYH A 308 | SAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 (-2.2A) | 1.19A | 6ineA-1pegA:17.7 | 6ineA-1pegA:29.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 8 | GLY A 160TRP A 161ASP A 202ASN A 241HIS A 242TYR A 283CYH A 306CYH A 308 | SAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 ( 2.3A) ZN A 4 (-2.2A) | 0.50A | 6ineA-1pegA:17.7 | 6ineA-1pegA:29.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1v9x | POLY (ADP-RIBOSE)POLYMERASE (Arabidopsisthaliana) |
PF00645(zf-PARP) | 5 | HIS A 55CYH A 23LYS A 24CYH A 26ILE A 30 | ZN A 200 (-3.1A) ZN A 200 (-2.3A)None ZN A 200 (-2.3A)None | 1.45A | 6ineA-1v9xA:undetectable | 6ineA-1v9xA:17.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2p2m | ACETYL-COENZYME ASYNTHETASE (Salmonellaenterica) |
PF00501(AMP-binding)PF13193(AMP-binding_C)PF16177(ACAS_N) | 5 | GLY A 387TRP A 414ASP A 411TYR A 398ILE A 361 | PRX A 998 (-3.4A)PRX A 998 (-3.4A)PRX A 998 (-3.6A)NoneNone | 1.46A | 6ineA-2p2mA:undetectable | 6ineA-2p2mA:16.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | ASN A 219HIS A 220TYR A 261CYH A 287LYS A 288CYH A 289 | SAM A 304 (-3.3A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A)None ZN A 300 ( 2.3A) | 0.83A | 6ineA-2r3aA:17.7 | 6ineA-2r3aA:29.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 151TRP A 152ASN A 219HIS A 220TYR A 261CYH A 287 | SAM A 304 (-3.5A)NoneSAM A 304 (-3.3A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 1.19A | 6ineA-2r3aA:17.7 | 6ineA-2r3aA:29.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A 151TRP A 152ASN A 219HIS A 220TYR A 261CYH A 287CYH A 289 | SAM A 304 (-3.5A)NoneSAM A 304 (-3.3A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) ZN A 300 ( 2.3A) | 0.24A | 6ineA-2r3aA:17.7 | 6ineA-2r3aA:29.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 6 | GLY A3840ASN A3906HIS A3907TYR A3944CYH A3957CYH A3959 | SAH A4971 ( 3.7A)SAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A) ZN A4970 ( 2.3A) ZN A4970 (-2.3A) | 0.25A | 6ineA-2w5zA:13.5 | 6ineA-2w5zA:26.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | LYS A 135GLY A 136TRP A 137ASN A 209HIS A 210CYH A 273 | NoneSAH A 305 (-3.8A)NoneSAH A 305 (-3.4A)None ZN A 304 ( 2.3A) | 1.31A | 6ineA-3bo5A:18.0 | 6ineA-3bo5A:28.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 8 | LYS A 135GLY A 136TRP A 137ASN A 209HIS A 210TYR A 248CYH A 273CYH A 275 | NoneSAH A 305 (-3.8A)NoneSAH A 305 (-3.4A)NoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) ZN A 304 ( 2.3A) | 0.48A | 6ineA-3bo5A:18.0 | 6ineA-3bo5A:28.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 16HIS A 206TYR A 252CYH A 274CYH A 276 | NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 0.92A | 6ineA-3n71A:5.8 | 6ineA-3n71A:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.39A | 6ineA-3n71A:5.8 | 6ineA-3n71A:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.36A | 6ineA-3n71A:5.8 | 6ineA-3n71A:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | LYS A 17GLY A 18HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.00A | 6ineA-3n71A:5.8 | 6ineA-3n71A:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | LYS A 17GLY A 18HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.32A | 6ineA-3n71A:5.8 | 6ineA-3n71A:19.44 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 8 | GLY A 102TRP A 103ASN A 169HIS A 170TYR A 207CYH A 219LYS A 220CYH A 221 | SAM A 237 ( 3.7A)NoneSAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 ( 2.3A)None ZN A 232 (-2.3A) | 0.53A | 6ineA-3ooiA:24.4 | 6ineA-3ooiA:41.42 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 6 | LYS A2150GLY A2151TRP A2152ASN A2217HIS A2218CYH A2268 | NoneSAM A 7 (-3.4A)NoneSAM A 7 (-3.9A)None ZN A 1 ( 2.5A) | 1.37A | 6ineA-3opeA:28.9 | 6ineA-3opeA:84.03 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 12 | LYS A2150GLY A2151TRP A2152ASP A2192ASN A2217HIS A2218TYR A2255GLN A2266CYH A2268LYS A2269CYH A2270ILE A2279 | NoneSAM A 7 (-3.4A)NoneSAM A 7 (-3.9A)SAM A 7 (-3.9A)NoneNoneSAM A 7 (-2.9A) ZN A 1 ( 2.5A)None ZN A 1 (-2.7A)None | 0.60A | 6ineA-3opeA:28.9 | 6ineA-3opeA:84.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4au7 | HISTONE-LYSINEN-METHYLTRANSFERASESUV420H2 (Mus musculus) |
PF00856(SET) | 5 | ASN A 182HIS A 183TYR A 217CYH A 229CYH A 231 | SAH A1247 (-3.1A)SAH A1247 (-4.6A)None ZN A1248 ( 2.3A) ZN A1248 ( 2.2A) | 0.43A | 6ineA-4au7A:7.4 | 6ineA-4au7A:22.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 8 | LYS A1560GLY A1561TRP A1562ASN A1628HIS A1629GLN A1676CYH A1678CYH A1680 | None0UM A1804 (-3.5A)None0UM A1804 (-3.3A)None0UM A1804 (-3.3A) ZN A1803 ( 2.2A) ZN A1803 (-2.2A) | 0.85A | 6ineA-4fmuA:23.6 | 6ineA-4fmuA:37.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4j8b | COATOMER ALPHASUBUNIT (Schizosaccharomycespombe) |
PF00400(WD40) | 5 | GLY A 214ASP A 233ASN A 216CYH A 218CYH A 142 | None | 1.49A | 6ineA-4j8bA:undetectable | 6ineA-4j8bA:20.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mi5 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A 628TRP A 629ASN A 693HIS A 694TYR A 731 | None | 0.43A | 6ineA-4mi5A:14.6 | 6ineA-4mi5A:29.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 8 | LYS A 456GLY A 457TRP A 458ASN A 551HIS A 552TYR A 593CYH A 612CYH A 614 | SAH A 801 (-4.7A)SAH A 801 (-3.6A)SAH A 801 (-4.9A)SAH A 801 (-3.2A)NoneNone ZN A 805 ( 2.4A) ZN A 805 ( 2.4A) | 0.30A | 6ineA-4qeoA:16.7 | 6ineA-4qeoA:21.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rjz | ABC TRANSPORTER,SUBSTRATE BINDINGPROTEIN (SUGAR) (Agrobacteriumfabrum) |
PF01547(SBP_bac_1) | 5 | GLY A 297ASN A 90HIS A 93LYS A 139ILE A 88 | None | 1.23A | 6ineA-4rjzA:undetectable | 6ineA-4rjzA:18.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4w2r | ENHANCER OF ZESTE 2POLYCOMB REPRESSIVECOMPLEX 2 SUBUNIT (Anoliscarolinensis) |
no annotation | 5 | GLY A 520TRP A 521ASN A 585HIS A 586TYR A 623 | CJD A 708 (-3.6A)NoneCJD A 708 (-3.5A)NoneNone | 0.36A | 6ineA-4w2rA:20.0 | 6ineA-4w2rA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 6 | GLY A5408ASN A5474HIS A5475TYR A5512CYH A5525CYH A5527 | SAH A5602 (-3.6A)SAH A5602 (-3.1A)NoneNone ZN A5601 ( 2.2A) ZN A5601 ( 2.2A) | 0.30A | 6ineA-4z4pA:15.4 | 6ineA-4z4pA:23.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cpr | HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1 (Homo sapiens) |
PF00856(SET) | 5 | ASN B 272HIS B 273TYR B 307CYH B 319CYH B 321 | SAM B 402 (-3.1A)SAM B 402 (-4.5A)539 B 403 ( 3.9A) ZN B 401 ( 2.3A) ZN B 401 ( 2.2A) | 0.49A | 6ineA-5cprB:7.5 | 6ineA-5cprB:25.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f59 | HISTONE-LYSINEN-METHYLTRANSFERASE2C (Homo sapiens) |
PF00856(SET) | 6 | GLY A4782ASN A4848HIS A4849TYR A4886CYH A4899CYH A4901 | SAH A5002 (-3.5A)SAH A5002 (-2.7A)SAH A5002 (-4.6A)None ZN A5001 ( 2.0A) ZN A5001 (-2.3A) | 0.34A | 6ineA-5f59A:15.5 | 6ineA-5f59A:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 6 | GLY A3840ASN A3906HIS A3907TYR A3944CYH A3957CYH A3959 | SAH A4001 (-3.4A)SAH A4001 (-3.0A)SAH A4001 (-4.9A)SAH A4001 (-4.9A) ZN A4002 ( 2.3A) ZN A4002 (-2.3A) | 0.24A | 6ineA-5f6lA:14.8 | 6ineA-5f6lA:22.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 16HIS A 207TYR A 240CYH A 262CYH A 264 | NoneNone6TM A 502 ( 3.6A) ZN A 505 (-2.3A) ZN A 505 (-2.4A) | 1.00A | 6ineA-5kjmA:6.1 | 6ineA-5kjmA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.46A | 6ineA-5kjmA:6.1 | 6ineA-5kjmA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 5 | LYS A 17GLY A 18HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.18A | 6ineA-5kjmA:6.1 | 6ineA-5kjmA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 5 | LYS A 17GLY A 18HIS A 207TYR A 240CYH A 262 | NoneSAM A 501 ( 4.1A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 1.36A | 6ineA-5kjmA:6.1 | 6ineA-5kjmA:19.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ls6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET)PF11616(EZH2_WD-Binding) | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | 74D A 809 ( 3.9A)None74D A 809 (-3.0A)NoneNone | 0.62A | 6ineA-5ls6A:17.8 | 6ineA-5ls6A:17.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 7 | GLY A1074TRP A1075ASN A1141HIS A1142TYR A1179CYH A1191CYH A1193 | SAM A1304 ( 3.2A)NoneSAM A1304 (-2.9A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 ( 2.3A) ZN A1301 (-2.3A) | 0.36A | 6ineA-5lsuA:24.6 | 6ineA-5lsuA:37.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5teg | N-LYSINEMETHYLTRANSFERASEKMT5A (Homo sapiens) |
PF00856(SET) | 5 | LYS A 226GLY A 227ASN A 298HIS A 299TYR A 336 | SAM A 401 (-4.6A)SAM A 401 ( 4.0A)SAM A 401 (-3.2A)NoneSAM A 401 (-4.8A) | 0.37A | 6ineA-5tegA:13.6 | 6ineA-5tegA:20.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1049ASN A1112HIS A1113GLN A1169CYH A1170 | SAM A1505 ( 3.9A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)None ZN A1504 (-2.2A) | 1.37A | 6ineA-5tuyA:17.6 | 6ineA-5tuyA:27.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1049TRP A1050ASN A1112HIS A1113CYH A1170 | SAM A1505 ( 3.9A)NoneSAM A1505 (-3.4A)SAM A1505 (-4.7A) ZN A1504 (-2.2A) | 1.26A | 6ineA-5tuyA:17.6 | 6ineA-5tuyA:27.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A1049TRP A1050ASN A1112HIS A1113TYR A1154CYH A1168CYH A1170 | SAM A1505 ( 3.9A)NoneSAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A) ZN A1504 (-2.2A) ZN A1504 (-2.2A) | 0.31A | 6ineA-5tuyA:17.6 | 6ineA-5tuyA:27.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1049TRP A1050HIS A1113TYR A1154CYH A1168 | SAM A1505 ( 3.9A)NoneSAM A1505 (-4.7A)SAM A1505 (-4.9A) ZN A1504 (-2.2A) | 1.38A | 6ineA-5tuyA:17.6 | 6ineA-5tuyA:27.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A1137TRP A1138ASN A1200HIS A1201TYR A1242CYH A1256CYH A1258 | SAM A3001 (-3.6A)NoneSAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 ( 2.4A) ZN A3005 (-2.3A) | 0.39A | 6ineA-5vsdA:17.9 | 6ineA-5vsdA:26.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A1137TRP A1138HIS A1201TYR A1242CYH A1258 | SAM A3001 (-3.6A)NoneSAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 (-2.3A) | 1.31A | 6ineA-5vsdA:17.9 | 6ineA-5vsdA:26.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wg6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,POLYCOMBPROTEIN SUZ12(E.C.2.1.1.43)CHIMERA (Homo sapiens) |
no annotation | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | A9G A9009 ( 4.2A)NoneA9G A9009 (-3.1A)NoneNone | 0.59A | 6ineA-5wg6A:18.0 | 6ineA-5wg6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xxg | - (-) |
no annotation | 5 | GLY A 15ASN A 205HIS A 206TYR A 239CYH A 261 | SAM A 502 ( 3.9A)SAM A 502 (-3.1A)None8HR A 501 ( 4.0A) ZN A 503 (-2.2A) | 0.65A | 6ineA-5xxgA:5.9 | 6ineA-5xxgA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5y3r | DNA-DEPENDENTPROTEIN KINASECATALYTIC SUBUNIT (Homo sapiens) |
PF00454(PI3_PI4_kinase)PF02259(FAT)PF02260(FATC)PF08163(NUC194) | 5 | GLY C3921ASP C3941HIS C3908CYH C3912ILE C3911 | None | 1.49A | 6ineA-5y3rC:undetectable | 6ineA-5y3rC:4.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6c8s | LOGANIC ACIDO-METHYLTRANSFERASE (Catharanthusroseus) |
no annotation | 5 | LYS A 39GLY A 40ASN A 83TYR A 31GLN A 316 | NoneNoneSAH A 401 (-3.8A)SAH A 401 (-4.5A)None | 1.31A | 6ineA-6c8sA:undetectable | 6ineA-6c8sA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 5 | GLY A1156TRP A1157ASN A1223HIS A1224CYH A1273 | SAM A1301 (-3.6A)NoneSAM A1301 (-3.2A)None ZN A1304 ( 2.3A) | 1.23A | 6ineA-6cenA:24.8 | 6ineA-6cenA:37.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 7 | GLY A1156TRP A1157ASN A1223HIS A1224TYR A1261CYH A1273CYH A1275 | SAM A1301 (-3.6A)NoneSAM A1301 (-3.2A)NoneSAM A1301 (-4.9A) ZN A1304 ( 2.3A) ZN A1304 (-2.3A) | 0.43A | 6ineA-6cenA:24.8 | 6ineA-6cenA:37.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 5 | GLY A1156TRP A1157HIS A1224TYR A1261CYH A1275 | SAM A1301 (-3.6A)NoneNoneSAM A1301 (-4.9A) ZN A1304 (-2.3A) | 1.42A | 6ineA-6cenA:24.8 | 6ineA-6cenA:37.97 |